Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

BUY
$117.37 - $139.17 $4.7 Million - $5.57 Million
40,046 Added 9936.97%
40,449 $5.2 Million
Q3 2022

Nov 09, 2022

BUY
$135.27 - $180.11 $54,513 - $72,584
403 New
403 $55,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.